Comment on the draft revised Guidance document: Switching a medicinal ingredient from prescription to non-prescription status
Current status: Open
Opened on April 21, 2022 and will close to new input on June 20, 2022.
Health Canada has updated the current guidance document for companies who wish to submit a request for a change from prescription to non-prescription status to:
- reflect a new process for prescription to natural health product switches
- provide more guidance to support companies in developing high quality switch submissions
For more information, please see the accompanying notice.
How to participate
Review the draft revised guidance document: Switching a medicinal ingredient from prescription to non-prescription status
Send us your input by email to email@example.com.
Who is the focus of this consultation?
Health Canada wants to hear from:
- all other interested parties
Goals of the consultation
We are seeking comments from industry and any other interested parties on the usefulness and clarity of the draft revised guidance document. We will use input gathered from this consultation to improve and finalize the document.
Bureau of Policy, Science and International Programs
Therapeutic Products Directorate
1600 Scott Street
Holland Cross, Tower B
2nd Floor, Address Locator 3102C5
Ottawa ON K1A 0K9
Report a problem or mistake on this page
- Date modified: